Novartis breaks ground on US radioligand therapy site
The construction is part of the company’s investment in US research and manufacturing
Read More
May 12, 2026 | News, Healthcare
The construction is part of the company’s investment in US research and manufacturing
Read MoreThe acquisition will advance innovation for patients with rare skin diseases
Read MoreMay 8, 2026 | News, Healthcare
Catalyst Pharmaceuticals is focused on novel medicines for rare diseases
Read MoreMay 8, 2026 | News, Healthcare
The company is focused on CAR-T cell therapy to treat multiple myeloma
Read MoreMay 7, 2026 | News, Healthcare
The company has also opened its first dedicated genetic medicine facility in Indiana in the US
Read MoreMay 6, 2026 | News, Regulatory
The mortality rates of UCDs exceeds 25%, with no curative treatment available for newborns
Read MoreNigel Breakwell was formerly Joint CEO of Edelman London and MD of WCG
Read MoreMay 1, 2026 | News, Healthcare
The data underlines the consequences of disrupted sleep for patients and caregivers
Read MoreApr 30, 2026 | News, Healthcare
The agreement gives Biogen full global rights to the investigational antibody across immune-mediated diseases
Read MoreApr 30, 2026 | News, Healthcare
The collaboration aims to improve patient identification and access to clinical trials
Read MoreApr 29, 2026 | News, Regulatory
The treatment can be used to delay the onset of clinical type 1 diabetes
Read MoreCOPD affects nearly 400 million people globally and is the third leading cause of death worldwide
Read More
